Circulogene Releases Dipstick Test For Tumor Analysis

By Ron Shinkman, Editor, Laboratory Industry Report Circulogene Theranostics has released a finger-stick test that allows clinicians to monitor the progression of cancer with just a drop or so of … [Read more...]

HCA Agrees to Pay $2 Million to Settle Claims of Unnecessary Lab Tests

By Kelly A. Briganti, Editorial Director, G2 Intelligence HCA Holdings, Inc. (formerly called Hospital Corporation of America) has settled health care fraud allegations relating to diagnostic testing … [Read more...]

CMS Estimates 2016 PFS to Have Positive Impact on Pathology, Independent Labs

While laboratories await a final rule for the 2016 Clinical Laboratory Fee Schedule implementing the Protecting Access to Medicare Act, the Centers for Medicare & Medicaid Services (CMS) recently … [Read more...]

FDA Issues Report Citing Case Studies It Argues Supports Need for More Oversight of LDTs

By Kelly A. Briganti, Editorial Director, G2 Intelligence The U.S. Food and Drug Administration (FDA) released a 30-plus page report yesterday detailing case studies it says demonstrate the need for … [Read more...]

DNA4Life Is Latest DTC Genetic Test Company to Receive FDA Letter

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Direct-to-consumer startup DNA4Life (Mandeville, La.) is the latest recipient of a letter from the U.S. Food and Drug Administration … [Read more...]

Harmonyx Tests to Be Distributed Through Rite Aid

By Ron Shinkman, Editor, Laboratory Industry Report Harmonyx, the Tennessee-based molecular laboratory, has struck a deal with pharmacy chain Rite Aid to sell its pharmacogenetic assays at its retail … [Read more...]

HCCA Offers Compliance Officer and Staff Compensation Survey

By Kelly A. Briganti, Editorial Director, G2 Intelligence Just in time for budget season, the Health Care Compliance Association has released a report demonstrating the resources health care … [Read more...]

OIG Releases 2016 Work Plan; Report on Lab Payments Expected

By Kelly A. Briganti, Editorial Director, G2 Intelligence Last week the OIG released its 2016 Work Plan that continues to name laboratories as a source of concern with regard to Medicare billing and … [Read more...]

Study Questions Clinical Impact of “Choosing Wisely” Recommendations

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies An initial assessment shows that the Choosing Wisely campaign is not having a large impact on changing use of low-value services, … [Read more...]

Ambry Genetics Introduces Panel to Trace Genetic Sources of Epileptic Seizures

By Ron Shinkman, Editor, Laboratory Industry Report Ambry Genetics has introduced a panel of genetic tests intended to gauge the underlying causes of epileptic seizures. The California-based … [Read more...]


(-00000g2)